A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus 
infection on her first day of life. The patient was treated with monoclonal 
antibodies (ZMapp), a buffy coat transfusion from an Ebola survivor, and the 
broad-spectrum antiviral GS-5734. On day 20, a venous blood specimen tested 
negative for Ebola virus by quantitative reverse-transcription polymerase chain 
reaction. The patient was discharged in good health on day 33 of life. Further 
follow-up consultations showed age-appropriate weight gain and neurodevelopment 
at the age of 12 months. This patient is the first neonate documented to have 
survived congenital infection with Ebola virus.